tiprankstipranks
Organo Corp. (JP:6368)
:6368
Japanese Market
Want to see JP:6368 full AI Analyst Report?

Organo Corp. (6368) Price & Analysis

1 Followers

6368 Stock Chart & Stats

¥15140.00
¥170.00(1.97%)
At close: 4:00 PM EST
¥15140.00
¥170.00(1.97%)

Bulls Say, Bears Say

Bulls Say
Consistent Revenue GrowthMulti-year top-line growth demonstrates durable demand for Organo's water treatment systems, chemicals and services across manufacturing, energy and healthcare. Consistent revenue expansion supports scale advantages, recurring service income, and provides a base to fund R&D and geographic expansion over the medium term.
Material Margin ExpansionSustained improvement in gross and net margins implies stronger pricing power, improved product mix and operational cost control. Higher margins translate into better cash conversion and reinvestment capacity, making profitability less sensitive to modest revenue slowdowns and strengthening long-term financial resilience.
Strong Recent Cash GenerationRobust 2026 operating and free cash flow, with FCF near 93% of net income, indicates high earnings quality and healthy cash conversion. Reliable cash generation supports capex, maintenance services, working capital needs and debt servicing, underpinning durable financial flexibility if performance holds.
Bears Say
Rising Debt In 2026An uptick in borrowings increases financing risk and heightens reliance on continued earnings and cash flow to keep leverage healthy. If growth or cash generation weakens, higher debt could constrain strategic investments or force tighter cash management, making capital structure less robust over a medium-term horizon.
Cash Flow VolatilityPast swings to negative operating and free cash flow signal execution and working-capital timing risks. This volatility reduces predictability of internally funded growth and increases dependency on external financing during down cycles, complicating planning for capex, maintenance contracts and debt repayment schedules.
Moderating Revenue GrowthSlower revenue expansion suggests a maturing growth cycle or tougher comps; without new product lines or market expansion, organic growth may stall. Extended moderation could pressure long-term earnings momentum and make it harder to sustain recent margin and cash-flow improvements.

6368 FAQ

What was Organo Corp.’s price range in the past 12 months?
Organo Corp. lowest stock price was ¥7880.00 and its highest was ¥20145.00 in the past 12 months.
    What is Organo Corp.’s market cap?
    Organo Corp.’s market cap is ¥654.38B.
      When is Organo Corp.’s upcoming earnings report date?
      Organo Corp.’s upcoming earnings report date is Aug 04, 2026 which is in 52 days.
        How were Organo Corp.’s earnings last quarter?
        Organo Corp. released its earnings results on May 13, 2026. The company reported ¥226.23 earnings per share for the quarter, beating the consensus estimate of ¥189.28 by ¥36.95.
          Is Organo Corp. overvalued?
          According to Wall Street analysts Organo Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Organo Corp. pay dividends?
            Organo Corp. pays a Semiannually dividend of ¥109 which represents an annual dividend yield of 1.43%. See more information on Organo Corp. dividends here
              What is Organo Corp.’s EPS estimate?
              Organo Corp.’s EPS estimate is 126.
                How many shares outstanding does Organo Corp. have?
                Organo Corp. has 46,359,700 shares outstanding.
                  What happened to Organo Corp.’s price movement after its last earnings report?
                  Organo Corp. reported an EPS of ¥226.23 in its last earnings report, beating expectations of ¥189.28. Following the earnings report the stock price went up 1.83%.
                    Which hedge fund is a major shareholder of Organo Corp.?
                    Currently, no hedge funds are holding shares in JP:6368
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Organo Corp.

                      Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured into two main divisions: the Water Treatment Engineering Business Unit and the Performance Products Business Unit. It offers a comprehensive portfolio of water purification solutions, encompassing various pure water systems such as reverse osmosis (RO), regenerative (automatic and manual), electric regeneration, desktop, cabinet, electrode ionization high-purity, cartridge, and two-stage RO systems. Additionally, Organo supplies ultrapure water systems, available in desktop and cabinet models, alongside final polishing units. The company's equipment range extends to include alkaline electrolyzed water production machinery, homogenizers, electro conductivity and resistivity meters, and ion exchange filters. Beyond physical systems, Organo Corporation provides specialized chemicals for water, wastewater, and RO treatment. Its extensive selection of industrial filters covers micro, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon filters. Commercial water purifiers are also part of its product offering. Organo's expertise is applied across numerous industries: delivering ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems for the electronics sector; constructing water supply and sewage treatment facilities; supplying purified water, UF water, and water for injection production and supply systems, coupled with consulting services, for the pharmaceutical industry; providing critical solutions for power generation, including condensate filters, demineralizers, reactor and fuel pool cleanup, makeup water, and waste water treatment systems; and implementing sugar refining systems and associated equipment.

                      Organo Corp. (6368) Earnings & Revenues

                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Kurita Water Industries
                      METAWATER Co
                      Takuma Co
                      Mitsubishi Kakoki Kaisha,Ltd.
                      Hitachi Zosen Corporation

                      Options Prices

                      Currently, No data available
                      ---
                      Popular Stocks